Prehypertension - Role of drug therapy

Indian Heart Journal

Volumn 60, Issue 1, 2008, Pages 5-8

  Fischer, Louie ^a   Puri, Aniket ^a   Saran, R K ^a  

^a UNIVERSITY OF LUCKNOW   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; THIAZIDE DIURETIC AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; PRACTICE GUIDELINE; PREHYPERTENSION; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; LIFE STYLE;

EID: 48749131471     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Levington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective studies collaboration. Age specific relevance of usual blood pressure to vascular mortality. A meta analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
2. Chobanian AV, Bakris GL, Black HR, et al. National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003;289:2560-2572.
3. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-1297.
4. Liszka HA, Mainous AG, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005;3:294-299.
5. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006;119:133-141.
6. Qureshi AI, Suri FK, Kirmani JF, Divani AA, Mohammed Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005;36:1859-1863.
7. Mainous AG, Everett CJ, Liszka H, King DE, Egan BM. Prehypertension and mortality in a nationally representative cohort. Am J Cardiol 2004;94:1496-1500.
8. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Int Med 2004;164:2113-2118.
9. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-1686.
10. Okosun IS, Boltri JM, Anochie LK, Chandra KMD. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risk of abdominal obesity. J Hum Hypertens 2004;18:849-855.
11. Tsai P-S, Ke T-L, Huang C-J, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005;223:1355-1360.
12. Cordero A, Laclaustra M, Leon M, et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. Am J Hypertens 2006;19:189-196.
13. Zhang Y, Lee ET, Devereux RB, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006;47:410-414.
14. King DE, Egan BM, Mainous AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens 2004;6:562-568.
15. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease. The ATTICA Study. Am J Hypertens 2004;17:568-573.
16. Julius S, Nesbitt SD, Egan BM, et al. Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006;354:1685-1697.
17. Appel LJ, Moore TJ, Obarzanek E, et al. DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-1124.
18. Sacks FM, Svetkey LP, Vollmer WM, et al. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001;344:3-10.
19. Appel LJ, Sacks FM, Carey VJ, et al. OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005;294:2455-2464.
20. Appel LJ, Champagne CM, Harsha DW, et al. Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003;289:2083-2093.
21. Elmer PJ, Obarzanek E, Vollmer WM, et al. PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Int Med 2006;144:485-495.